Talazoparib Tosylate

CAS 1207456-01-6 2 FDA-DMF suppliersSmall Molecule

Overview

Talazoparib Tosylate is a potent inhibitor of poly (ADP-ribose) polymerase (PARP) used in the treatment of specific types of breast cancer. It works by impairing DNA repair pathways, leading to cancer cell death.

Therapeutic areas

OncologyBreast Cancer

Related APIs

Paclitaxel
33 suppliers
Palbociclib
23 suppliers
Exemestane
18 suppliers
Fulvestrant
17 suppliers
Abemaciclib
14 suppliers
Trastuzumab
3 suppliers
Lapatinib
3 suppliers
Alpelisib
2 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo